Related Experiment Video
Updated: May 7, 2026

In Vivo Real-Time Study of Drug Effects on Carotid Blood Flow in the Ovine Fetus
Published on: April 28, 2023
Unexpected Fetal Supraventricular Tachycardia Temporally Associated With Maternal Antihistamine Use: A Case Report
Khadijeh Riazi Kermani1, Shahrokh Rajaei1, Razieh Moazami Goudarzi2
1Department of Pediatric Cardiology, Clinical Research Development Center of Children's Hospital, Hormozgan University of Medical Sciences, Bandar Abbas, Hormozgan, Iran, hums.ac.ir.
Fetal supraventricular tachycardia (SVT) represents the most common cause of sustained fetal tachyarrhythmia and may result in significant hemodynamic compromise when persistent. Data regarding the cardiovascular effects of maternal antihistamine use during pregnancy remain limited. We report a near-term fetus with sustained SVT temporally associated with maternal ingestion of cetirizine and an antihistamine-decongestant combination for the treatment of allergic rhinitis. Owing to the persistence of the tachyarrhythmia during hospitalization, transplacental antiarrhythmic therapy with flecainide was initiated. After 48 h of treatment, successful rhythm control was achieved. Concurrent use of cetirizine and an antihistamine decongestant in a single dose during pregnancy resulted in sustained SVT in the fetus, necessitating treatment. Therefore, the use of cetirizine in the third trimester and antihistamine decongestants throughout pregnancy requires further investigation.
Fetal supraventricular tachycardia (SVT) represents the most common cause of sustained fetal tachyarrhythmia and may result in significant hemodynamic compromise when persistent. Data regarding the cardiovascular effects of maternal antihistamine use during pregnancy remain limited. We report a near-term fetus with sustained SVT temporally associated with maternal ingestion of cetirizine and an antihistamine-decongestant combination for the treatment of allergic rhinitis. Owing to the persistence of the tachyarrhythmia during hospitalization, transplacental antiarrhythmic therapy with flecainide was initiated. After 48 h of treatment, successful rhythm control was achieved. Concurrent use of cetirizine and an antihistamine decongestant in a single dose during pregnancy resulted in sustained SVT in the fetus, necessitating treatment. Therefore, the use of cetirizine in the third trimester and antihistamine decongestants throughout pregnancy requires further investigation.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Dysrhythmias II: Classification of Tachyarrhythmias
Allergic Reactions
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Allergic Reactions: Anaphylaxis

